ClinicalTrials.govpublic full text
Phase II Study of Weekly Paclitaxel/Nab-Paclitaxel, Pembrolizumab, and Mirabegron for Recurrent Ovarian Cancer
ovarian cancer, immunotherapy, pembrolizumab
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 249581
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.